Summary report on the ISOBM TD-4 Workshop: Analysis of 56 monoclonal antibodies against the MUC1 mucin

Tumor Biology

Volumn 19, Issue SUPPL.1, 1997, Pages 1-20

  Price, M R ^a   Rye, P D ^b   Petrakou, E ^a   Murray, A ^a   Brady, K ^a   Imai, S ^c   Haga, S ^d   Kiyozuka, Y ^e   Schol, D ^f   Meulenbroek, M F A ^f   Snijdewint, F G M ^f   Von Mensdorff Pouilly, S ^f   Verstraeten, R A ^f   Kenemans, P ^f   Blockzjil, A ^g   Nilsson, K ^g   Nilsson, O ^g   Reddish, M ^h   Suresh, M R ^h   Koganty, R R ^h   Fortier, S ^h   Baronic, L ^h   Berg, A ^h   Longenecker, M B ^h   Hilkens, J ⁱ   Boer, M ⁱ   Karanikas, V ^j   McKenzie, I F C ^j   Galanina, O E ^k   Simeoni, L A ^k   Ter Grigoryan, A G ^k   Belyanchikov, I M ^k   Bovin, N V ^k   Cao, Y ^l   Karsten, U ^l   Dai, J ^m   Allard, W J ^m   Davis, G ^m   Yeung, K K ^m   Hanisch, F G ⁿ   Lloyd, K O ^o   Kudryashov, V ^o   Sikut, R ^p   Sikut, A ^p   Zhang, K ^p   Baeckstrom D ^p   Hansson, G C ^p   Reis, C A ^q,r   Hassan, H ^r   Bennett, E P ^r   Claussen, H ^r   Norum, L ^b   Varaas, T ^b   Kierulf, B ^b   Nustad, K ^b   Ciborowski, P ^s   Konitzki, W M ^s   Magarian Blander, J ^s   Finn, O J ^s   Hilgers, J ^f   more..

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Nara Pref Inst of Public Health   (Japan)

^d NARA MEDICAL UNIVERSITY   (Japan)

^e KANSAI MEDICAL UNIVERSITY   (Japan)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g Fujirebio Diagnostics Inc   (Sweden)

^h Biomira Inc   (Canada)

ⁱ NETHERLANDS CANCER INSTITUTE   (Netherlands)

^j AUSTIN HEALTH   (Australia)

^k SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^l MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^m BAYER CORPORATION   (United States)

ⁿ UNIVERSITY OF COLOGNE   (Germany)

^o MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^p UNIVERSITY OF GOTHENBURG   (Sweden)

^q UNIVERSITY OF COPENHAGEN   (Denmark)

^r UNIVERSITY OF PORTO   (Portugal)

^s UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Epitope mapping; Monoclonal antibodies; MUC1 mucin; Reactivity, specificity and affinity; Synthetic peptides and glycopeptides

Indexed keywords

GLYCOPEPTIDE; MONOCLONAL ANTIBODY; MUCIN;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; CONFERENCE PAPER; EPITOPE MAPPING; GENE LOCATION; GENE TARGETING; LIGAND BINDING; MACROMOLECULE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; TANDEM REPEAT;

EID: 6844257550     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056500     Document Type: Conference Paper

References (38)

1. Baeckström D, Nilsson O, Price MR, Lindholm L, Hansson GC: Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody. Cancer Res 1993;53:755-761.
2. Xing PX, Tjandra JJ, Stacker SA, Teh JG, Thompson CH, McLaughlin PJ, McKenzie IF: Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol 1989;67:183-195.
3. Xing PX, Reynolds K, Tjandra JJ, Tang XL, McKenzie IF: Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies. Cancer Res 1990;50:89-96.
4. Xing PX, Tjandra JJ, Reynolds K, McLaughlin PJ, Purcell DF, McKenzie IF: Reactivity of anti-human milk fat globule antibodies with synthetic peptides. J Immunol 1989;142:3503-3509.
5. Xing PX, Reynolds K, Pietersz GA, McKenzie IF: Effect of variations in peptide sequence on anti-human milk fat globule membrane antibody reactions. Immunology 1991;72:304-311.
6. Xing PX, Prenzoska J, McKenzie IF: Epitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies. Mol Immunol 1992;29:641-650.
7. Teh JG, Xing PX, McKenzie IF: Anti-colorectal carcinoma monoclonal antibodies reactive with human milk fat globular membranes. Immunol Cell Biol 1990;68:207-216.
8. Apostolopoulos V, Xing PX, Trapani JA, McKenzie IF: Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein. Br J Cancer 1993;67:713-720.
9. Xing PX, Prenzoska J, Quelch K, McKenzie IF: Second generation anti-MUC1 peptide monoclonal antibodies. Cancer Res 1992;52:2310-2317.
10. Hanisch F-G, Stadie T, Bosslet K: Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats. Cancer Res 1995;55:4036-4040.
11. Kufe D, Inghirami G, Abe M, Hayes D, Justi Wheeler H, Schlom J: Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984;3:223-232.
12. Perey L, Hayes DF, Maimonis P, Abe M, O'Hara C, Kufe DW: Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 1992;52:2563-2568.
13. Martínez L, Castilla JA, Blanco N, Perán F, Herruzo A: CA 125, CA 15,3, CA 27.29, CEA, β-hCG and α-fetoprotein levels in cyst fluid of breast macrocysts. Int J Gynecol Obstet 1995;48:187-192.
14. Reddish MA, Helbrecht N, Almeida AF, Madiyalakan R, Suresh MR, Longenecker BM: Epitope mapping of mab B27.29 within the peptide core of the malignant breast carcinoma-associated mucin antigen coded for by the human MUC1 gene. J Tumor Marker Oncol 1992;7:19-27.
15. Linsley PS, Brown JP, Magnani JL, Horn D: Monoclonal antibodies reactive with mucin glycoproteins found in sera from breast cancer patients. Cancer Res 1988;48:2138-2148.
16. Magnani JL, Linsley PS, Brown JP, Horn D: Monoclonal antibody Onc-M26, which detects elevated levels of mucin in sera from breast cancer patients, binds a sugar sequence in sialylated lacto-N-fucopentaose III. IXth Symposium, on glycoconjugates, Jerusalem, 1987, abstr F69.
17. Stacker SA, Thompson C, Riglar C, McKenzie IF: A new breast carcinoma antigen defined by a monoclonal antibody. J Natl Cancer Inst 1985;75:801-811.
18. Hilkens J, Buijs F, Hilgers J, Hageman P, Calafat J, Sonnenberg A, van der Valk M: Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 1984;34:197-206.
19. Neubauer A, Musch R, Thalmann U, Grosser H, Laser J, Lodden-kemper R, Huhn D: Evidence of cross-reactivity of 'carcinoma-specific' KC4 monoclonal antibody with activated mesothelial cells and phytohemagglutinin-stimulated lymphocytes. Oncology 1988;45:380-383.
20. Kochevar J: A renal cell carcinoma neoplastic antigen detectable by immunohistochemistry is defined by a marine monoclonal antibody. Cancer 1987;59:2031-2036.
21. Bray KR, Koda JE, Gaur PK: Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker. Cancer Res 1987:47:5853-5860.
22. Nilsson O, Karlsson B, Lindholm L, Pettersson A: Development of assays for determination of MUC-1 breast cancer antigen; in Klapdor R (ed): Current Tumor Diagnosis: Applications, Clinical Relevance, Research Trends. Munich, Zuckschwerdt, 1994, pp 130-133.
23. Cordell J, Richardson TC, Pulford KA, Ghosh AK, Gatter KC, Heyderman E, Mason DY: Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 1985;52:347-354.
24. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R, Lamport D: Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 1987;47:5476-5482.
25. Burchell J, Taylor-Papadimitriou J, Boshell M, Gendler S, Duhig T: A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immuno-dominant epitopes. Int J Cancer 1989;44:691-696.
26. Fukushi Y, Nudelman E, Levery SB, Hakomori S, Rauvala H: Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem 1984;259:10511-10517.
27. Taylor Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF: Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with cells in culture. Int J Cancer 1981;28:17-21
28. Price MR, Hudecz F, O'Sullivan C, Baldwin RW, Edwards PM, Tendler SJ: Immunological and structural features of the protein core of human polymorphic epithelial mucin. Mol Immunol 1990;27:795-802.
29. Stahli C, Takacs B, Miggiano V, Staehelin T, Carmann H: Monoclonal antibodies against antigens on breast cancer cells. Experientia 1985;41:1377-1381.
30. Price MR, Pugh JA, Hudecz F, Griffiths W, Jacobs E, Symonds IM, Clarke AJ, Chan WC, Baldwin RW: C595 - a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. Br J Cancer 1990;61:681-686.
31. Rye PD, Bell SC, Walker RA: Immunohistochemical expression of tumour-associated glycoprotein and polymorphic epithelial mucin in the human endometrium during the menstrual cycle. J Reprod Fertil 1993;97:551-556.
32. Rye PD, Bovin NV, Vlasova EV, Walker RA: Monoclonal antibody LU-BCRU-G7 against a breast tumour-associated glycoprotein recognizes the disaccharide Galβ1-3GlcNAc. Glycobiology 1995;5:385-389.
33. Ceriani RL, Peterson JA, Lee JY, Moncada R, Blank EW: Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somat Cell Genet 1983;9:415-427.
34. Devine PL, Clark BA, Birrell GW, Layton GT, Ward BG, Alewood PF, McKenzie IFC: The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Cancer Res 1991;51:5826-5836.
35. Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J, Burchell J: A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 1988;263:12820-12823.
36. Rye PD, Walker RA: Prognostic value of a breast cancer-associated glycoprotein detected by monoclonal antibody LU-BCRU-G7. Eur J Cancer 1994;30:1007-1012.
37. Laine RA: A calculation of all possible oligosaccharide isomers, both branched and linear yields 1.05 × 1,012 structures for a reducing hexasaccharide. Glycobiology 1994;4:1-9.
38. Hilkens J, Ligtenberg MJL, Vos HL, Litvinov SV: Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 1992;17:359-363.